Abiopharma

Clinical trial NCT07562152: start date: 2026-06-01 → 2026-06-05.

Clinical trial NCT07338942: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT03762759 updates: 1. completion date: 2025-12-31 → 2030-05-19 2. primary completion date: 2025-05-31 → 2025-05-19

RBLX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Notifies Roblox (RBLX) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026

Digital Realty Welcomes Governor Abbott’s Initiative for Responsible and Transparent Data Center Investment in Texas

Clinical trial NCT03131934 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-05-15 → 2026-03-12 3. enrollment: 18 → 4 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07502495 updates: 1. completion date: 2027-07-01 → 2027-09-01 2. primary completion date: 2027-06-01 → 2027-03-01

Clinical trial NCT07293689: start date: 2026-08-31 → 2026-12-01.

General Announcement: THE PROPOSED ENTRY INTO AN ANNUAL DISTRIBUTION AGREEMENT AS AN INTERESTED PERSON TRANSACTION

Clinical trial NCT05568459 updates: 1. completion date: 2026-05-21 → 2026-08-21 2. primary completion date: 2026-05-21 → 2026-08-21